UNSPSC 51202602: Anisperimus

This classification denotes an immunosuppressant with the molecular formula C18H39N7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0514P112G. The term ANISPERIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, list 44). As of Q4 2014, ANISPERIMUS remains US FDA's Preferred Term for this commodity. Anisperimus bears US NLM identifiers UMLS ID C2698118 and NCI Concept Code C77593.

Most nations, for tariff and trade purposes, schedule Anisperimus under HS 29252900 and SITC 51482 (for the most current information on WCO designations on anisperimus and salts thereof, please see Committee proceedings HSC/53, NC2004B1b Ann. O/6, 2014). SMILES: C[C@H](CCNCCCCNC(=O)OCC(=O)NCCCCCCNC(=N)N)N.

UNSPSC 51202602 Anisperimus is a Commodity code under which state and local governments procure pharmaceutical products and related medical supplies, including antibiotics, opioid-antagonist medications, and drug deactivation systems for public health and emergency response programs. Recent solicitations show demand for both high-volume warehouse pharmaceutical distribution and specialized public health supplies. The issuing bodies include state health departments and county government agencies, with activity spanning multi-year contracts valued in the millions of dollars and smaller competitive procurements for specific community health initiatives.

Activity under the code reaches at least Illinois and Florida based on recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a 12-month initial term and renewal options for years 2 and 3. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, response deadline July 26, 2026, including all shipping and delivery costs in the bid price.